Cargando…
Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials
INTRODUCTION: Delays in adequate antimicrobial treatment contribute to high cost and mortality in sepsis. Polymerase chain reaction (PCR) assays are used alongside conventional cultures to accelerate the identification of microorganisms. We analyze the impact on medical outcomes and healthcare costs...
Autores principales: | Lehmann, Lutz E, Herpichboehm, Bernd, Kost, Gerald J, Kollef, Marin H, Stüber, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219292/ https://www.ncbi.nlm.nih.gov/pubmed/20950442 http://dx.doi.org/10.1186/cc9294 |
Ejemplares similares
-
Polymerase chain reaction detection of sepsis-inducing pathogens in blood using SepsiTest™
por: Disqué, Claudia, et al.
Publicado: (2008) -
Mortality, intensive care treatment, and cost evaluation: Role of a polymerase chain reaction assay in patients with sepsis
por: Andrej, Markota, et al.
Publicado: (2017) -
Rapid identification of sepsis-causing pathogens with polymerase chain reaction and microarray-based assay
por: Järvinen, Anna-Kaarina, et al.
Publicado: (2008) -
The role of polymerase chain reaction and its newer developments in feline medicine
por: Lutz, H., et al.
Publicado: (1999) -
Pathogen-Negative Sepsis—An Opportunity for Antimicrobial Stewardship
por: Lockhart, Gabriel C, et al.
Publicado: (2019)